George N. Thalmann

University Hospital of Bern, University of Bern

Papers

10

Total Citations

3,559

H-Index

7

About

George N. Thalmann is a leading urologic oncologist whose research has fundamentally shaped the management of muscle-invasive and metastatic bladder cancer. As a key contributor to the European Association of Urology (EAU) Guidelines, his work—including the landmark 2020 guidelines (over 2,100 citations) and the 2023 update—provides the global standard for evidence-based treatment. Dr. Thalmann has been instrumental in advancing surgical techniques, particularly through systematic reviews and consensus panels on robot-assisted radical cystectomy, demonstrating improved oncologic and functional outcomes. His research also champions enhanced recovery protocols in urological surgery, addressing critical perioperative care needs. With over 3,500 citations across his most influential papers, Dr. Thalmann’s contributions bridge rigorous guideline development and innovative surgical practice, making him a pivotal figure in the fight against bladder cancer. His work continues to guide clinicians and researchers toward more effective, patient-centered care.

Research Focus

Key Achievements

7
H-Index
10
Papers
3,559
Total Citations
356
Avg Citations/Paper
🏆 Most Cited Paper
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
2,139 citations · 2020
📈 Most Prolific Year: 2015 (3 Papers)
🤝 Key Collaborators: 64
🏛 Institutions: University Hospital of Bern, University of Bern

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago